首页> 外文期刊>Journal of Scientific & Industrial Research >Three new methods for the assay of albendazole using N-chlorosuccinimide
【24h】

Three new methods for the assay of albendazole using N-chlorosuccinimide

机译:N-氯代琥珀酰亚胺测定阿苯达唑的三种新方法

获取原文
获取原文并翻译 | 示例
       

摘要

Two titrimetric and one spectrophotometric methods are described for the determination of albendazole in pure form and in formulations. In direct titrimetric procedure (Method A), the drug is titrated directly with N-chlorosuccinimide solution in hydrochloric acid medium using indigo carmine as indicator. In back titrimetry (Method B) the drug is treated with a measured excess of the oxidant in acetic acid medium followed by the determination of the residual oxidant iodometrically. Spectrophotometry (Method C), involves the addition of a known excess of N-chlorosuccinimide to albendazole in hydrochloric acid medium followed by the determination of surplus oxidant by oxidation and complexation reactions involving iron (Ⅱ) and thiocyanate. The absorbance of the resulting orange-red colour was measured at 480 nm and related to albendazole concentration. Titrimetric assays are based on a 1:2 reaction stiochiometry between albendazole and N-chlorosuccinimide. Direct titrimetry is applicable over 2-13 mg range, and 4-14 mg of albendazole could be determined by back titration method. In Spectrophotometry the regression analysis of Beer's law plot showed a good correlation between 0.62-10.0 μg/mL albendazole with a correlation coefficient of -0.9964. The molar absorptivity and Sandell sensitivity were 4.14 x 10~4 L/moL/cm and 18. 82 ng/cm~2, respectively. The limits of detection and quantification, respectively, were 0.61 and 2.02 μg/mL. The proposed methods were applied successfully for the determination of albendazole in pharmaceutical formulations with mean recoveries of 97.36 to 102.36 per cent. The excipients present in formulations did not interfere. The accuracy and reliability of the methods were further established by parallel determination by the reference method, and by recovery studies.
机译:描述了两种滴定法和一种分光光度法测定纯形式和制剂中的阿苯达唑。在直接滴定法(方法A)中,使用靛蓝胭脂红作为指示剂,在盐酸介质中用N-氯代琥珀酰亚胺溶液直接滴定药物。在反滴定法(方法B)中,在乙酸介质中用定量过量的氧化剂处理药物,然后碘量法测定残留的氧化剂。分光光度法(方法C)包括在盐酸介质中向阿苯达唑中添加已知过量的N-氯代琥珀酰亚胺,然后通过涉及铁(Ⅱ)和硫氰酸盐的氧化和络合反应测定过剩的氧化剂。在480 nm处测量得到的橙红色的吸光度,并且与阿苯达唑浓度有关。滴定分析是基于阿苯达唑和N-氯代琥珀酰亚胺之间的1:2反应化学计量。直接滴定法适用于2-13 mg范围,通过反滴定法可以测定4-14 mg阿苯达唑。在分光光度法中,比尔定律图的回归分析显示0.62-10.0μg/ mL的阿苯达唑之间具有良好的相关性,相关系数为-0.9964。摩尔吸光度和Sandell灵敏度分别为4.14×10〜4 L / moL / cm和18。82ng / cm〜2。检测限和定量限分别为0.61和2.02μg/ mL。所提出的方法已成功用于药物制剂中阿苯达唑的测定,平均回收率为97.36%至102.36%。制剂中存在的赋形剂没有干扰。通过参考方法的平行测定和回收率研究,进一步确定了方法的准确性和可靠性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号